Exclusive: J&J out of race for Pfizer’s $20 billion consumer unit as deadline looms
LONDON/NEW YORK/FRANKFURT (Reuters) – Johnson & Johnson has pulled out of the race to buy Pfizer’s consumer health business, leaving GlaxoSmithKline and Reckitt Benckiser among those preparing bids, according to...
Read More